Cargando…

Methadone-mediated sensitization of glioblastoma cells is drug and cell line dependent

PURPOSE: d,l-methadone (MET), an analgesic drug used for pain treatment and opiate addiction, has achieved attention from oncologists and social media as possible chemoensitizing agent in cancer therapy, notably brain cancer (glioblastoma multiforme, GBM). MET has been reported to enhance doxorubici...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haas, Bodo, Ciftcioglu, Janine, Jermar, Sanja, Weickhardt, Sandra, Eckstein, Niels, Kaina, Bernd
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original Article – Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872955/ https://www.ncbi.nlm.nih.gov/pubmed/33315125 http://dx.doi.org/10.1007/s00432-020-03485-3

Ejemplares similares

Cytotoxic and Senolytic Effects of Methadone in Combination with Temozolomide in Glioblastoma Cells
por: Kaina, Bernd, et al.
Publicado: (2020)

Thioredoxin Confers Intrinsic Resistance to Cytostatic Drugs in Human Glioma Cells
por: Haas, Bodo, et al.
Publicado: (2018)

Inhibition of the PI3K but not the MEK/ERK pathway sensitizes human glioma cells to alkylating drugs
por: Haas, Bodo, et al.
Publicado: (2018)

Are There Thresholds in Glioblastoma Cell Death Responses Triggered by Temozolomide?
por: He, Yang, et al.
Publicado: (2019)

Abrogation of Cellular Senescence Induced by Temozolomide in Glioblastoma Cells: Search for Senolytics
por: Beltzig, Lea, et al.
Publicado: (2022)

Against Repurposing Methadone for Glioblastoma Therapy
por: Vatter, Tatjana, et al.
Publicado: (2020)

Dabigatran antagonizes growth, cell‐cycle progression, migration, and endothelial tube formation induced by thrombin in breast and glioblastoma cell lines
por: Vianello, Fabrizio, et al.
Publicado: (2016)

Temozolomide in Glioblastoma Therapy: Role of Apoptosis, Senescence and Autophagy. Comment on Strobel et al., Temozolomide and Other Alkylating Agents in Glioblastoma Therapy. Biomedicines 2019, 7, 69
por: Kaina, Bernd
Publicado: (2019)

Crizotinib targets in glioblastoma stem cells
por: Junca, Audelaure, et al.
Publicado: (2017)

Patient-derived glioblastoma stem cells transfer mitochondria through tunneling nanotubes in tumor organoids
por: Pinto, Giulia, et al.
Publicado: (2021)

Clinical pharmacology and regulatory consequences of GnRH analogues in prostate cancer
por: Eckstein, Niels, et al.
Publicado: (2014)

Accumulation of Temozolomide-Induced Apoptosis, Senescence and DNA Damage by Metronomic Dose Schedule: A Proof-of-Principle Study with Glioblastoma Cells
por: Beltzig, Lea, et al.
Publicado: (2021)

Efficacy of D,L-methadone in the treatment of glioblastoma in vitro
por: Brawanski, Konstantin, et al.
Publicado: (2018)

Bioinformatics analysis of potential core genes for glioblastoma
por: Zhang, Yu, et al.
Publicado: (2020)

Impairment of cell adhesion and migration by inhibition of protein disulphide isomerases in three breast cancer cell lines
por: Young, Henry S., et al.
Publicado: (2020)

Characterization and drug sensitivity of a novel human ovarian clear cell carcinoma cell line genomically and phenotypically similar to the original tumor
por: Franklin, Miriam, et al.
Publicado: (2018)

Methadone Potentiates the Cytotoxicity of Temozolomide by Impairing Calcium Homeostasis and Dysregulation of PARP in Glioblastoma Cells
por: Honc, Ondrej, et al.
Publicado: (2023)

Dcf1 induces glioblastoma cells apoptosis by blocking autophagy
por: Luo, Guanghong, et al.
Publicado: (2021)

HCK promotes glioblastoma progression by TGFβ signaling
por: Wang, Zhenlin, et al.
Publicado: (2020)

Tanshinone IIA induces cell death via Beclin‐1‐dependent autophagy in oral squamous cell carcinoma SCC‐9 cell line
por: Qiu, Ye, et al.
Publicado: (2018)

Oncogenic Activity of Glucocorticoid Receptor β Is Controlled by Ubiquitination-Dependent Interaction with USP49 in Glioblastoma Cells
por: Hu, Yaling, et al.
Publicado: (2022)

Methadone does not potentiate the effect of doxorubicin in canine tumour cell lines
por: Cueni, Claudia, et al.
Publicado: (2020)

Dihydroartemisinin initiates ferroptosis in glioblastoma through GPX4 inhibition
por: Yi, Renxin, et al.
Publicado: (2020)

Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion
por: Restall, Ian, et al.
Publicado: (2018)

Potential anticancer activities of Rhus coriaria (sumac) extract against human cancer cell lines
por: A. Gabr, Sami, et al.
Publicado: (2021)

ONC201 induces the unfolded protein response (UPR) in high‐ and low‐grade ovarian carcinoma cell lines and leads to cell death regardless of platinum sensitivity
por: Rumman, Marufa, et al.
Publicado: (2021)

Senescence Is the Main Trait Induced by Temozolomide in Glioblastoma Cells
por: Beltzig, Lea, et al.
Publicado: (2022)

Parvimonas micra infection enhances proliferation, wound healing, and inflammation of a colorectal cancer cell line
por: Hatta, Muhammad Nur Adam, et al.
Publicado: (2023)

Rad51 and BRCA2 - New Molecular Targets for Sensitizing Glioma Cells to Alkylating Anticancer Drugs
por: Quiros, Steve, et al.
Publicado: (2011)

EphrinB2 drives perivascular invasion and proliferation of glioblastoma stem-like cells
por: Krusche, Benjamin, et al.
Publicado: (2016)

Establishment and characterization of a novel lymphangiosarcoma cell line (MO-LAS) compared with the hemangiosarcoma cell line (ISO-HAS)
por: Masuzawa, Mikio, et al.
Publicado: (2012)

Single-cell chromatin accessibility profiling of glioblastoma identifies an invasive cancer stem cell population associated with lower survival
por: Guilhamon, Paul, et al.
Publicado: (2021)

First-line ICIs in renal cell carcinoma
por: Fiorentino, Vincenzo, et al.
Publicado: (2023)

Coculture with astrocytes reduces the radiosensitivity of glioblastoma stem-like cells and identifies additional targets for radiosensitization
por: Rath, Barbara H, et al.
Publicado: (2015)

U-251 revisited: genetic drift and phenotypic consequences of long-term cultures of glioblastoma cells
por: Torsvik, Anja, et al.
Publicado: (2014)

An Aurora kinase inhibitor, AMG900, inhibits glioblastoma cell proliferation by disrupting mitotic progression
por: Ryu, Jaewook, et al.
Publicado: (2018)

MYST1/KAT8 contributes to tumor progression by activating EGFR signaling in glioblastoma cells
por: Dong, Zhen, et al.
Publicado: (2019)

Siglec-15 recognition of sialoglycans on tumor cell lines can occur independently of sialyl Tn antigen expression
por: Murugesan, Gavuthami, et al.
Publicado: (2020)

Better retention of Malaysian opiate dependents treated with high dose methadone in methadone maintenance therapy
por: Mohamad, Nasir, et al.
Publicado: (2010)

Platinum resistance in breast and ovarian cancer cell lines
por: Eckstein, Niels
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_6k66r4prl0q2tk1fcsbg8fu8m9